Chinese Journal of Cancer Research (CJCR; Print ISSN: 1000-9604; Online ISSN:1993-0631; www.thecjcr.org) is published by AME Publishing Company (www.amepc.org) in association with Chinese Anti-Cancer Association.It was launched in March 1995 as a quarterly publication and is now published bi-monthly since February 2013.

CJCR is published bi-monthly in English, and is an international journal devoted to the life sciences and medical sciences. It publishes peer-reviewed original articles of basic investigations and clinical observations, reviews and brief communications providing a forum for the recent experimental and clinical advances in cancer research. This journal is indexed in Science Citation Index Expanded (SCIE), PubMed/PubMed Central (PMC), Scopus, SciSearch, Chemistry Abstracts (CA), the Excerpta Medica/EMBASE, Chinainfo, CNKI, CSCI, etc.

CJCR encourages submissions from all areas of cancer research. Topics of particular interest include, but are not limited to, cancer prevention, cancer etiology and epidemiology, molecular cell biology, gene diagnosis and gene therapy, tumor pathology, imaging diagnosis of cancer, surgical oncology, medical oncology, radiation oncology, biological therapy of cancer, minimally invasive surgery, molecular targeted therapy for cancer, interventional radiology, as well as early detection, diagnosis and treatment in various cancers.

Submission Turnaround Time

Submission to First Editorial Decision: 1-2 weeks
Peer review to Decision: 4-6 weeks
Acceptance to Publication: 1-2 months. Original Articles are listed as priority.

Authors should submit their manuscript online at www.thecjcr.org. However, if you have problems please contact the Editorial Office at editor@thecjcr.org.

Impact Factor(2014): 1.935
Journal Citation Reports®, Thomson Reuters

Published by: AME Publishing Company
Address: Room 604 6/F Hollywood Center, 77-91 Queen's road, Sheung Wan, HongKong.
Tel: +86 20 66355775; Fax: +852 3188 5078.
Email: editor@amepc.org

(updated on 2015-8-10 )